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Abstract: Antibiotic resistance has been one of the biggest threats to global health. Despite the
available prevention and control strategies and efforts in developing new antibiotics, the need remains
for effective approaches against antibiotic resistance. Efficient strategies to cope with antimicrobial
resistance require a quantitative and deeper understanding of microbial behavior, which can be
obtained using different techniques to provide the missing pieces of the current antibiotic-resistance
puzzle. Microfluidic-microscopy techniques are among the most promising methods that contribute
modernization of traditional assays in microbiology. They provide monitoring and manipulation
of cells at micro-scale volumes. Here, we combined population-level, culture-based assays
with single-cell resolution, microfluidic-microscopy systems to investigate isoniazid response of
Mycobacterium smegmatis penicillin-binding protein (PBP) mutant. This mutant exhibited normal
growth in plain medium and sensitivity to stress responses when treated with thermal stress (45 ◦C),
detergent stress (0.1% sodium dodecyl sulfate), acid stress (pH 4.5), and nutrient starvation (1XPBS).
The impact of msm0031 transposon insertion on drug-mediated killing was determined for isoniazid
(INH, 50 µg/mL), rifampicin (RIF, 200 µg/mL), ethionamide (ETH, 200 µg/mL), and ethambutol
(EMB, 5 µg/mL). The PBP mutant demonstrated remarkable isoniazid-killing phenotype in batch
culture. Therefore, we hypothesized that single-cell analysis will show increased lysis kinetics and
fewer intact cells after drug treatment. However, the single-cell analysis data showed that upon
isoniazid exposure, the percentage of the intact PBP mutant cells was 24%, while the percentage of the
intact wild-type cells was 4.6%. The PBP mutant cells exhibited decreased cell-lysis profile. Therefore,
the traditional culture-based assays were not sufficient to provide insights about the subpopulation
of viable but non-culture cells. Consequently, we need more adequate tools to be able to comprehend
and fight the antibiotic resistance of bacteria.
Keywords: penicillin-binding protein (PBP); microfluidics; antibiotics; M. smegmatis; single-cell
resolution; microscopy
1. Introduction
Antibiotic resistance remains one of the biggest threats to global health in spite of being an old
fight for humankind. Better prevention and control plans and effective strategies against antibiotic
resistance are needed [1]. The World Health Organization (WHO) categorizes emergence and spread of
antimicrobial resistance as a high priority action, and aims to ensure its prevention and treatment with
effective and safe medicine while developing new antibiotics or alternative medicine to antibiotics [2,3].
Efficient strategies to manage antimicrobial resistance require a quantitative and deeper understanding
of microbial behavior. Combining the qualities of different techniques will provide development of
novel approaches for antibiotic-resistance problems.
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From Antonie van Leeuwenhoek to the 2000s, observation and investigation of microorganisms
and development of antibiotics mostly relied on population-level assays, known as “bulk assays” [4].
The majority of the laboratories in academia, clinics, or pharmaceutical companies has continued to
actively use these tools and methods. However, significant effort has been recently dedicated to increase
the resolution of culture-based assays via the contributions of scientists from diverse disciplines,
ranging from engineering, physics, statistics, medicine, and chemistry [5–8]. Our aim is to better
understand microbial heterogeneity and antibiotic responses, not only during discrete physiochemical
interactions at discrete-time points, but also to characterize their actions as dynamic, continuous
time events while mimicking their pathophysiological conditions, such as microenvironments for
biofilms [9]. Using microfabricated tools, scientists reported the importance of the microenvironment
on motility, distribution and dynamics of bacterial culture [10–13]. In contrast to statically culturing
cells in flasks, bacteria are cultured in microchannels, fed by a continuous medium flow where the
antibiotic can be added into the medium, and the antibiotic response of the cells can be dynamically
observed at single-cell resolution [10]. Therefore, these technologies have great potential for observing
and quantifying the microenvironmental conditions that shape the survival strategies of bacteria,
such as biofilms. Biofilms are strictly regulated by their surrounding microenvironments [14–16];
these might be able to be tightly controlled using microfluidic devices. Moreover, microfluidic cell
culture systems have provided great potential for culturing currently viable but non-culturable bacteria
(VBNCs) in laboratories, while discovering the mechanisms behind their phenotype [11]. Pioneering
work by Dr. Austin and his co-workers has combined theoretical and experimental methods to
unearth the cryptic complexity of bacterial evolution in studying the antibiotic response of the cells
in dynamic, spatially heterogeneous microenvironments [17–19]. Dr. Ackermann and his group
presented novel data about molecular microbial ecology using time-lapse microscopy and single-cell
analysis [19–23]. From the fundamental side, these studies provide an ability to culture microbes
in dynamic environments to reveal their role in the environment, ecology, and nutrient cycle. From
the applied side, understanding of the underlying molecular mechanisms they develop to adapt to
different stresses will be transferable to benefits for health, ecology and science. Uncovering the
mystery of adaptation strategies to survive in the microbial word requires exploring bacteria in their
complex, natural microenvironments; otherwise, impaired or underestimated results will mask their
variability, and avoid conditions that cause antibiotic-resistant infections. Therefore, single-cell level
and culture-based assays are complementary pieces of the current state-of-the-art.
In this study, we investigate the stress response of Mycobacterium smegmatis (M. smegmatis)
transposon mutant, msm0031::Tn, using microfluidics and bulk assays. M. smegmatis is a rod-shaped
bacterium with a complex cell wall [24,25]. It is a model organism for human pathogen, Mycobacterium
tuberculosis (M. tuberculosis). However, it is a non-pathogen, fast-growing organism that requires a
biosafety level 1 laboratory. It shares more than 2000 homologous genes with M. tuberculosis [26,27].
The product of the msm0031 gene is a penicillin-binding protein (PBP) required for cell division and
involved in cell wall formation. The M. smegmatis msm0031::Tn mutant has remarkable isoniazid-killing
phenotype both at population and single-cell levels.
PBPs are sets of membrane-bound enzymes, enrolled in glycan chain assembly and peptide
cross-linking of bacterial peptidoglycan. The underlying beta-lactam resistance mechanism relies on
modification of the PBPs in terms of copy number or affinity towards beta-lactams. Contribution of PBP
mutations has been continuously investigated in various bacterial species regarding the development
of tolerance to several antibiotics, including penicillin [28]. Here, we studied the influence of the
PBP mutation on the isoniazid (INH)-killing kinetics of M. smegmatis using the method that was
firstly reported by Wakamato et al. to show that the persistence of antibiotic stressed mycobacteria
is dynamic [10]. Next, we used this approach to investigate the INH-killing profile of the NADH
(reduced form of Nicotinamide adenine dinucleotide) pyrophosphate mutant of M. smegmatis [29].
Our findings reported that the NADH pyrophosphate mutant cells had a low level of cell division
and a high level of cell lysis, and that they were incapable of regrowth upon INH removal. Contrary
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to our microfluidic-based approaches, in literature most mycobacterial studies have investigated
PBPs using transposon mutants with specific phenotypes in batch culture [30]. Patru and Pavelka
investigated the role of PonA2 and PonA3 in mycobacterial peptidoglycan biology. They reported that
∆PonA2 strains have decreased susceptibility to the beta-lactams ampicillin and ceftriaxone, increased
susceptibility to rifampin (RIF), and no susceptibility difference for isoniazid (INH), ethambutol
(EMB), vancomycin, or imipenem. ∆PonA3 strains did not affect the antibiotic susceptibility. PonA2
has a role in adaptation to survival and these cells have spherical morphology due to weakened
cell wall integrity. Bansal et al. characterized putative DD-carboxypeptidase (DD-CPase) via cloning
MSMEG_2433 gene in Escherichia coli (E.coli) and showed that MSMEG_2433 is both a DD-CPase and
beta-lactamase [31]. Enany and co-workers presented the role of mycobacterial DNA-binding protein 1,
which controls suppression of DNA synthesis, respiration, and fatty acid synthesis, and protection
against reactive oxygen species, so prevents rapid cell death in the stationary phase and provides
long-term survival of mycobacteria [32]. Moreover, Flores, Parsons and Pavelka performed transposon
mutagenesis of the beta-lactamase mutants of M. tuberculosis and M. smegmatis and screened for
cephalosporin and ceftriaxone hypersusceptible mutants. Their results provided unknown proteins
that are involved in peptidoglycan biosynthesis, cell division, or other cell envelope processes [33].
Kieser et al. performed whole-genome transposon mutagenesis screens in M. tuberculosis deleted
for PonA1, PonA2, and LdtB, major peptidoglycan enzymes. They verified that M. tuberculosis uses
alternative pathways to produce peptidoglycan; either PonA1 or PonA2, which genetically interact
with LdtB, is required for M. tuberculosis growth that also provides differential susceptibility to
antibiotics [34].
To our knowledge, the msm0031::Tn mutant has not been studied in detail using both culture-based
and microfluidic-microscopy-based assays. Our findings present the effect of the msm0031 gene
in increased INH-susceptibility. Our single-cell analysis complements the data obtained from
culture-based assays while challenging the definition of death for bacteria.
2. Materials and Methods
2.1. Growth of the Cells
M. smegmatis cells were grown in standard Middlebrook 7H9 medium (BD/Difco) containing
0.085% NaCl, 0.5% albumin, 0.2% glucose, 0.5% glycerol, and 0.05% Tween-80 at 37 ◦C with shaking
at 200 rpm [35]. Optical density of the cells (absorbance at 600 nm) was measured to determine the
growth of the cells via a spectrophotometer (Thermo Scientific biomate 5, Waltham, MA, USA).
2.2. Antibiotic Responses
Agar plates were prepared with 15 g/L Bacto agar (Sigma-Aldrich, St. Louis, MO, USA) and
15.5 g/L Luria Miller broth base (Sigma-Aldrich) in water. M. smegmatis cells were grown to OD600
of 0.5–1 and diluted to OD600 of 0.05, corresponding to ~107 CFU/mL, in fresh 7H9 medium. Serial
10-fold dilutions were made using 100-µL cultures and 900-µL 1X PBS—0.025% Tween solutions in
5-mL polypropylene tubes. Appropriate dilutions of 100 µL were plated onto agar-based media to
ensure that the serial dilutions would give at least one countable plate. Unless otherwise specified,
antibiotics were used at the following concentrations: INH: 50 µg/mL, RIF: 200 µg/mL, ETH: 200
µg/mL, EMB: 5 µg/mL. Then, plates were incubated at 37 ◦C and colonies were enumerated on day 4.
2.3. Environmental Stresses
Sensitivity of the msm0031::Tn mutant and wild-type cells to thermal stress (45 ◦C), the detergent
sodium dodecyl sulphate (0.1%. SDS), acidic pH (pH 4.5), and nutrient starvation by incubation of
cells in phosphate-buffered saline (PBS) was determined [35].
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2.4. Minimum Inhibitory Concentration (MIC)
M. smegmatis cells were grown to OD600 of 0.5–1 and diluted to OD600 of 0.05 in fresh 7H9 medium.
Then 10-fold serial dilutions were plated on Luria broth (LB) agar solid plates containing various
concentrations of INH. MIC was defined as the lowest concentration of drug required seeing minimum
bacterial colony-forming unit (CFU).
2.5. Transposon (Tn) Mutagenesis and Identification of the msm0031::Tn Mutant
The fMycoMarT7 transposon donor phagemid (provided by Eric Rubin, Harvard School of
Public Health), which carries a selectable marker for kanamycin resistance, was used to mutagenize a
strain of M. smegmatis mc2155 [32]. For identification of the msm0031::Tn mutant, genomic DNA was
extracted using lysozyme, proteinase K digestion, cetrimide saline, and chloroform extraction [33].
Then, genomic DNA was digested with BamHI (New England BioLabs, NEB, Ipswich, MA, USA),
the digested DNA was ligated with T4 ligase (NEB) and transformed into Pir1 competent E. coli
cells (Invitrogen, Carlsbad, CA, USA). Kanamycin-resistant colonies were selected; plasmid DNA
was isolated, and sequenced using the primer cttctgagcgggactctgggg (Supplementary Materials,
Figures S1–S3) [29,36].
2.6. Microfluidic Chip and Live-Cell Imaging
The microfluidic chip provided growth of the cells between the coverslip (#1) and the
semipermeable membrane (Spectrum Lab, MWCO:8, Rancho Dominguez, CA, USA), which was
under the Polydimethylsiloxane (PDMS, Sylgard 184) microfluidic channels with the same diameter
(22 mm) of the coverslip, Figure 1. The microfluidic network considered a series of parallel channels in
between the inlet and outlet with a 50 µm × 50 µm height and width [10]. Wakamato et al. presented
the design and fabrication of the device [10]. Continuous medium flow (25 µL/min) was provided
using standard, silicone tubing (ID: 0.076 cm, OD: 0.165 cm, HelixMark, Würselen, Germany) and a
syringe pump (World Precision Instruments, Sarasota, FL, USA). Medium switching was very practical
for on-chip drug exposures [10]. Thanks to our microfluidic network, the cells were sandwiched
between the membrane and coverslip, and the microchannels were on top of the membrane; therefore,
the depth of the microchannels did not introduce any problems, such as cell-to-cell overlapping or
focusing of cells (Figure 1).
Micromachines 2018, 9, x FOR PEER REVIEW  4 of 12 
 
2.4. Minimum Inhibitory Concentration (MIC) 
M. smegmatis cells were grown to OD600 of 0.5–1 and diluted to OD600 of 0.05 in fresh 7H9 
medium. Then 10-fold serial dilutions were plated on Luria broth (LB) agar solid plates containing 
various concentrations of INH. MIC was defined as the lowest concentration of drug required seeing 
minimum bacterial colony-forming unit (CFU). 
2.5. Transposon (Tn) Mutagenesis and Identification of the msm0031::Tn Mutant 
The fMycoMarT7 transposon donor phagemid (provided by Eric Rubin, Harvard School of 
Public Health), which car ies a selectable marker for kanamycin resistance, was used to mutagenize 
a strain of M. smegmatis mc2155 [32]. For identific tion of the msm0031::Tn mutant, genomic DNA 
was xt cted using lysozyme, proteinase K digestion, c trimide saline, and chloroform extraction 
[33]. Then, genomic DNA was digested with BamHI (New England BioLabs, NEB, Ipswich, MA, 
USA), the digested DNA was ligated with T4 ligase (NEB) and transformed into Pir1 competent E. 
coli cells (Invitrogen, Carlsbad, CA, USA). Kanamycin-resistant colonies were selected; plasmid 
DNA was isolated, and sequenced using the primer cttctgagcgggactctgggg (Supplementary 
Materials, Figures S1–S3) [29,36]. 
2.6. Microfluidic Chip and Live-Cell Imaging 
Th  microfluidic chip provided growth of the cells between the cover lip (#1) and the 
semiperm able membrane (Spectrum Lab, MWCO:8, Rancho D inguez, CA, USA), which was 
under the P lydimethylsiloxane (PDMS, Sylgard 184) microfluidic channels with the same diameter 
(22 mm) of the coverslip, Figure 1. The mic ofluidic network considered a series of parallel channels 
in between the inlet and outlet with a 50 µm × 50 µm height and width [10]. Wakamato et al. 
presented the design and fabrication of the device [10]. Continuous medium flow (25 µL/min) was 
provided using standard, silicone tubing (ID: 0.076 cm, OD: 0.165 cm, HelixMark, Würselen, 
Germany) and a syringe pump (World Precision Instrum nts, Sarasota, FL, USA). Medium 
witching was very practical for on-chip drug exposures [10]. Thanks to our microfluidic network, 
the cells were sandwiched between the membrane and coverslip, and the microc annels were on top 
of the membrane; therefore, the depth of the microchannels did not introduc  any problems, such as 
c ll-to-cell overlapping or focusing of cells (Figure 1).  
Moreover, the microfluidic device enabled the onitoring of single-cells during the 
pre-antibiotic, antibiotic, and post-antibiotic periods for 72 h, which traditional m thods c not 
provide. Live-cell imaging was performed using an inverted, auto ated, time-lapse fluorescent 
micros ope (Olympus IX75, Hamburg, Germany) equipped with a Hamamatsu ORCA-AG CCD 
camera. Using 100× oil-immersion objective (UPLFLN) images were acquir d on phase and 
fluor scent channels (TRIS-r d, GFP-green, exposure: 150 µs). The microfluidic d vice lo ded with 
cells was mounted on the microscope inside a temperature-controlled chamber (37 °C). 
 
Figure 1. Schematics of the on-chip experiments and PDMS microfluidic device. Figure 1. Sche atics of the on-chip experi ents and PD S icrofluidic device.
Moreover, the microfluidic device enabled the monitoring of single-cells during the pre-antibiotic,
antibiotic, and post-antibiotic periods for 72 h, which traditional methods cannot provide. Live-cell
imaging was performed using an inverted, automated, time-lapse fluorescent microscope (Olympus
IX75, Hamburg, Germany) equipped with a Hamamatsu ORCA-AG CCD camera. Using 100×
oil-immersion objective (UPLFLN) images were acquired on phase and fluorescent channels (TRIS-red,
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GFP-green, exposure: 150 µs). The microfluidic device loaded with cells was mounted on the
microscope inside a temperature-controlled chamber (37 ◦C).
2.7. Image Analysis
Time-lapse fluorescent movies were analyzed using cell counter plugin in ImageJ. The numbers of
lysis and division events were manually counted using the cell counter plugin for every 4-h time frame.
When the cells lysed, they lost their fluorescence. When the cells divided, their siblings appeared and
expressed fluorescence.
In order to ensure the division and lysis events, the movies, obtained via merging the fluorescence
and phase contrast images, were analyzed. The figures were plotted in Prism4.
2.8. Statistical Analysis
The Student’s unpaired t-test (two-tailed) was used to assess statistical significance of pairwise
comparisons. p-values were calculated using online software, GraphPad QuickCalcs. p-values < 0.05
present statistically significant differences. Three independent experiments were performed and used
to determine the p-values.
3. Results
3.1. Batch-Cultue Behavior of the msm0031 Transposon Mutant and Wild-Type M. smegmatis Cells
Growth and stress responses of the cells, particularly to antibiotics, was conducted using
population-level, batch-culture assays.
Growth was determined by monitoring optical absorbance of the msm0031 transposon mutant
and wild-type (WT) cells in standard 7H9 medium. The msm0031 transposon mutant was capable of
growth with WT kinetics (Figure 2; Supplementary Materials, Figures S4 and S6).
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3.2. Drug Specificity
The impact of msm0031 transposon insertion drug-mediated kil i termined for INH,
ETH, EMB, and RIF, Figure 3.
Since the influence of INH for the PBP mutant was investigated, the MIC value of the msm0031
transposon mutant for INH was determined as 3.125 µg/mL. The INH-MIC value of the wild-type
M. smegmatis cells was measured as 3.125 µg/mL.
The drug s ecificity of h msm0031 transposo mutant was tested to determine whether
the mutant is phenotypically tolerant to a wid rang of antibioti s (Supplemen ary Materials,
Figures S5–S7). Comparison of persistence phenotype rates was defined as the fractional survival ratio
(FSR). The FSR values were calculated as percentage survival of mutant cells divided by percentage
survival of wild-type cells after 48 h of exposure to INH, RIF, ETH, and EMB [32]. FSR > 1 persisted
better than WT; FSR < 1 showed decreased persistence compared to wild-type. p-values were calculated
using the Student’s unpaired t-test. p-values < 0.05 were statistically significant. Mean values and
standard errors were calculated from data obtained in three independent experiments (Table 1).
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Table 1. Fractional survival ratio (FSR) for the msm0031 transposon mutant and wild-type M. smegmatis
cells (*** p < 0.0001, ** p < 0.01, * p < 0.05).
Antibiotics FSR± SE WT FSR± SE msm0031
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3.3. Stress Responses
The responses of the msm0031::Tn mutant to other external stresses, including thermal stress
(elevated temperatures of 45 ◦C), detergent stress (0.1% sodium dodecyl sulfate), acid stress
(pH 4.5), and nutrient starvation (incubation in phosphate-buffered saline, PBS 1X), were investigated
(Figure 4) [37].
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3.4. On-Chip Behavior of the msm0031 Transposon Mutant and Wild-Type M. smegmatis Cells
On-chip experiments allowed us to simultaneously observe single cells in a mixture of both
wild-type cells (green fluorescent) and the msm0031 transposon mutant cells (red fluorescent) while
excluding the possibility that differences in the growth environment might be the cause of the observed
phenotypes in previous assays (Supplementary Materials, Figure S4). Figure 1 illustrates how on-chip
experiments were conducted and image analysis was performed.
The on-chip INH-killing experiment consisted of three steps: growth of the cells in standard 7H9
medium; three-day INH exposure for differential killing; and drug withdrawal to observe recovery
from the antibiotic treatment [29]. Observation of the cells was achieved using live-cell imaging on the
fluorescent microscopy (Supplementary Movie). Figure 5 demonstrates the on-chip behavior of the
msm0031::Tn mutant and wild-type cells at single-cell resolution.
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and 70 resumed growth after INH washout. Regarding the M. smegmatis msm0031::Tn mutant, the 
number of intact cells following INH exposure was 795; 605 of these were PI-positive, 190 were 
Figure 5. Quantitative single-cell analysis using on-chip-microscopy images of wild-type M. smegmatis
(A) and the msm0031::Tn mutant (B) during 72 h of INH (50 µg/mL) exposure. The first panel illustrates
the cumulative behaviour of the cells as a composite of lysis and division events. The second panel
shows the number of cells that lysed during each successive time interval. The third panel presents the
number of cells that divided in each successive time interval. The data present the mean and standard
errors of three points in the microfluidic device.
After drug withdrawal, an end-point staining was performed with propidium iodide (PI). In order
to quantify the PI-positive, PI-negative and regrowth subpopulations of the cells, we used wild-type
cells expressing green fluorescent protein, msm0031 transposon mutant cells expressing no flouresecent
protein, and PI (red dye). For M. smegmatis wild-type cells, the number of intact cells following INH
exposure was 512; 417 of these were PI-positive, 24 were PI-negative, one cell lysed, and 70 resumed
growth after INH washout. Regarding the M. smegmatis msm0031::Tn mutant, the number of intact
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cells following INH exposure was 795; 605 of these were PI-positive, 190 were PI-negative, 4 resumed
growth, and none of the cells lysed after INH washout. Figure 6 shows the comparison of WT and the
msm0031 transposon mutant behavior at ten different points in the microfluidic device.
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4. Discussion
This work presented the behaviour of M. smegmatis msm0031 transposon mutant and wild-type
cells both at single-cell level in conjunction with a microfluidic-microscopy system and at
population-level using traditional, batch-culture assays. Since INH targets the mycobacterial
envelope [29] and the msm0031 gene is a PBP involved in cell wall formation and cell division [28–31],
our investigations mainly focused on the INH-killing profile of the M. smegmatis msm0031
transposon mutant.
In our studies, we obtained the M. smegmatis msm0031 mutant using transposon mutagenesis,
which is one of the common genetic tools to obtain the specific mycobacterium phenotypes [33,34].
In literature, most of the PBP-related studies were performed using culture-based assays. These studies
mainly focused on either antibiotic action mechanisms or bacterial peptidoglycan biosynthesis
concepts. For the first concept, the antibiotic-killing profile of the PBP mutants was mostly
questioned to understand how beta-lactam antibiotics work and how mycobacteria develops resistance
to beta-lactams, such as penicillin [28], ampicillin, ceftriaxone [30], vancomycin, imipenem [31],
cephalosporin, and ceftriaxone [32]. Among these studies, only Pature and Pavelka’s research focused
on INH susceptibility of the ∆PonA2 strains in addition to beta-lactams while studying the role of
the PonA2 and PonA3 genes in mycobacterial peptidoglycan formation [30]. The hypothesis of PBP
enrollment in the cell envelope and cell division processes was mostly reported for the PonA1, PonA2
and LdtB proteins [33]. Next, they focused on purification and biochemical characterization of PBP
proteins of mycobacterium. Patru and Pavelka’s study reported the relationship between the spherical
morphology of the cells and their antibiotic susceptibility via PBP proteins.
Here, we implemented single-cell level, microfluidic-microscopy and population-level,
culture-based assays to investigate M. smegmatis transposon mutant, msm0031. First, we confirmed that
there was no growth phenotype for the msm0031 transposon mutant. Next, we obtained the msm0031
deletion mutant. The msm0031 deletion strain presented hindered growth, defective cell separation,
higher transcript levels and a cell area twice as large compared to wild-type cells (Supplementary
Materials, Figures S3–S5). Then, we performed batch-culture drug susceptibility assays using INH,
ETH, EMB, and RIF [38]. Among them, RIF killed both the PBP mutant and wild type cells until
48 h; afterwards, rifampicin degraded and the cells regrew (Figure 3) [39–41]. The PBP mutant
presented enhanced killing profile for INH, ETH, and EMB; these drugs targets cell wall components
(Figure 3, Table 1). In addition, we determined the sensitivity of the msm0031 transposon mutant
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to thermal stress, detergent, acidic pH, and nutrient starvations to confirm the INH-killing profile
of the msm0031 transposon mutant was not mainly due to impaired cell wall formation (Figure 4).
Moreover, the drug-specificity assays were performed for the ∆msm0031 deletion strain. The deletion
strain exhibited similar killing patterns to the transposon mutant (Supplementary Materials, Figure S5).
When we complemented both the transposon mutant and deletion strain, we could not retain the
wild-type phenotype (Supplementary Materials, Figures S2, S6 and S7).
Next, we observed and quantified INH-killing kinetics of the msm0031 transposon mutant
and wild-type cells at micro scale using a microfluidic device. The main advantages of using
a microfluidic-microscopy system in our experiments were the ability to track single cells from
pre-antibiotic to post-antibiotic periods, to perfuse continuous medium and drug (which excluded
drug degradation and waste accumulation), and to quantify morphology, lysis and division of the cells
in real-time. Our microfluidic assays showed that our hypothesis based on bulk assays, which was
that enhanced INH-killing of the msm0031 transposon mutant was due to elevated lysis of the cells in
the presence of INH, was wrong. The msm0031 transposon mutant formed fewer colonies on standard
LB plates compared to wild-type cells during the INH exposure in the batch culture. Therefore,
as a consequence of the microfluidic assay, our prediction was increased cell lysis and a decreased
number of intact cells for the msm0031 transposon mutant. However, quantitative single-cell analysis
presented contradictory results. It showed that upon INH-treatment, 24% of the PBP mutant cells were
intact and PI negative, whereas this subpopulation was only 4.6% of the wild-type cells. In addition,
both the division and lysis kinetics of the PBP transposon mutant and wild-type cells were quite
different (Figure 5). The killing events of the PBP mutant between 40–48 h might be due to the
tolerance of the cell wall, which cannot balance the osmatic pressure and, hence, most of the cells burst.
Actually, the batch culture-killing curve also shows rapid killing around 30–48 h, as shown in Figure 3.
The wild-type cells lysed more than the PBP transposon mutant and its cumulative lysis was more
than its cumulative division. Hence, the wild-type cells were rapidly killed after 12 h of drug exposure
in the microfluidic assay (32 h), which is also consistent with the batch-culture INH-killing profile.
On the other hand, the msm0031 transposon mutant actively divided up to 52 h and almost stopped
its division at 60 h. Furthermore, it lysed less than wild-type cells. Finally, when we removed INH,
13.7% of the wild-type cells and 0.5% of the PBP mutant cells resumed growth. The subpopulation of
the PBP mutant, which cannot form colonies, recovered growth but remained intact and PI-negative.
It might be viable and non-culturable cell populations that could actively grow when specific culturing
conditions were provided. The msm0031 transposon mutant cells have always followed the same
trends for the INH-killing profile, although the maximum lysis of the PBP mutant cells has varied
within the 30–48 h of INH exposure.
The possible explanation for impaired colony formation and enhanced killing rate of the
msm0031::Tn mutant could be explained by PbpA, since PbpA enrols at the final stage of the
peptidoglycan synthesis. Another possible explanation might be that the msm0031 gene is a part
of a conserved gene cluster that is involved in coordinated regulation of cell division and/or cell
elongation, and that interruption of any of these genes alters phenotypes of the cells (Supplementary
Materials, Figures S1–S3).
To the best of our knowledge, our study is one of the first that combines culture-based assay results
with on-chip-microscopy assays in regards to the drug killing aspects of the M. smegmatis transposon
mutant, msm0031. In order to advance our knowledge about mechanisms of drug actions and functions
of genes, we could incorporate the results obtained using different techniques at different scales,
such as culture-based, population-level and microfluidic-microscopy-based, single-cell level assays.
The results we obtained are the missing pieces of the puzzle of understanding how individuality of
cells plays a role in the antibiotic response of the population, especially regarding the phenomenon of
natural antibiotic resistance.
Micromachines 2018, 9, 561 10 of 12
Supplementary Materials: The following are available online at http://www.mdpi.com/2072-666X/9/11/561/
s1. Figure S1: mRNA expressions for M. smegmatis msm0031 transposon mutant. Bars represent the ratio of
mRNA levels relative to sigA, a constitutive gene whose expression remains relatively unchanged. Number of
transcript copies determined by qRT-PCR using gene-specific primers as listed below. Figure S2: Chromosomal
locus encoding the msm0031 gene in M. smegmatis. Location of the transposon insertion indicated by vertical
arrow. Figure S3: Confirmation for the msm0031 deletion mutant measuring the mRNA expression levels. Bars
represent the ratio of mRNA levels relative to sigA, a constitutive gene whose expression remains relatively
unchanged. Number of transcript copies determined by qRT-PCR using gene specific primers as listed in materials
and methods. The RT-qPCR experiments were performed at least 2 times. Figure S4: Deletion of msm0031 gene
altered morphology and growth rate. Deletion of msm0031 gene affected colony morphology (A), limited growth
in standard 7H9 broth (B). Bright field images showed PBPA-inactivated cells were longer (C). Fluorescence
microscopy of msm0031 deletion mutant transformed with Wag31–GFP showed defective septum formation in the
presence of INH (D). Using time-lapse movies generation time was calculated as 3 hours for the msm0031 deletion
cells (E). The measured cell area for the msm0031 deletion strain was 2 times larger than WT (F). Figure S5: Batch
culture drug-killing assays for the msm0031 deletion mutant. WT M. smegmatis and the msm0031 deletion mutant
were treated with INH-50 µg/mL (A), ETH-200 µg/mL (B), EMB-5 µg/mL (C), and RIF-200 µg/mL (D). Serial
dilutions of cultures were plated at the indicated time points to determine the CFU count. INH and EMB results
are the mean ± standard error from 3 independent cultures; ETH and RIF results are the mean ± standard error
from 3 independent cultures. Figure S6: Growth curves for the complemented msm0031 transposon and deletion
strains. Growth was monitored by measuring culture turbidity (OD600 nm) at the indicated time points. Figure
S7: Batch culture drug-killing assays for the complemented msm0031 deletion and transposon strains. WT M.
smegmatis, the complemented msm0031 deletion and complemented msm0031 transposon mutant were treated
with INH-50 µg/mL (A), ETH-200 µg/mL, (B), EMB-5 µg/mL (C), and RIF-200 µg/mL (D). Serial dilutions of
cultures were plated at the indicated time points to determine the Log CFU. The results are representatives at least
two independent experiments. Video S1: PBP mutant.
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